Showing results (161-170 of 966) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|December 7, 2016
From tumour heterogeneity to advances in precision treatment of colorectal cancerCornelis J A Punt, Miriam Koopman, Louis VermeulenNature Reviews. Clinical Oncology|December 14, 2016
Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancerAngela George, Stan Kaye, Susana BanerjeeNature Reviews. Clinical Oncology|April 23, 2014
Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.Nature Reviews. Clinical Oncology|March 7, 2019
Mechanisms of resistance to CAR T cell therapyNirali N Shah, Terry J FryNature Reviews. Clinical Oncology|December 30, 2016
The landscape of new drugs in lymphomaAnas Younes, Stephen Ansell, Nathan Fowler, et al.Nature Reviews. Clinical Oncology|March 15, 2017
The high price of anticancer drugs: origins, implications, barriers, solutionsVinay Prasad, Kevin De Jesús, Sham MailankodyNature Reviews. Clinical Oncology|November 14, 2018
Addendum: Low-value approvals and high prices might incentivize ineffective drug developmentVinay Prasad, Christopher McCabe, Sham MailankodyNature Reviews. Clinical Oncology|March 26, 2014
Determining the optimal dose in the development of anticancer agentsRon H J Mathijssen, Alex Sparreboom, Jaap VerweijNature Reviews. Clinical Oncology|November 30, 2016
The need for multidisciplinarity in specialist training to optimize future patient careAlison C Tree, Victoria Harding, Aneel Bhangu, et al.Nature Reviews. Clinical Oncology|March 12, 2014
Building capacity for sustainable research programmes for cancer in AfricaIsaac Adewole, Damali N Martin, Makeda J Williams, et al.Pageof 97